Training for Academic Hematology

学术血液学培训

• 批准号: 7587791
• 负责人: VICTOR JACK MARDER
• 金额: $ 5.63万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-07-01 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7587791
• 关键词: Academic Training; Hematology

This application is for competitive renewal of a PHS Institutional National Service Award at the David Geffen School of Medicine at UCLA to prepare fellows for an academic career in Hematology. This award was nitiated in July, 2002, and supports 4 fellowship slots in years 2 and 3 of Hematology/Medical Oncology training. Of 11 fellows who have entered the program, 4 are currently in training and 7 have completed their fellowship, of which 4 are on the full-time faculty at UCLA, two are in clinical trial development with industry, and one has entered clinical practice. The faculty consists of 31 academic scientists and physicians, grouped into four areas of mutual research interest, Hematopoiesis and Stem Cell Biology (Kenneth Dorshkind, PhD, Director), Leukemia (Gary Schiller, MD, Director), Lymphocyte Biology and Lymphoma (Alan Lichtenstein, MD, Director) and Hemostasis, Thrombosis and Vascular Biology (Victor Marder, MD, Director). All the faculty have extramural research grant support, including 24 (77%) with NIHgrants. Interaction with other training programs in complementary disciplines emphasizes our goal of interactive basic and translational research careers. A research retreat is; held each spring, during which time each mentor presents an overview of the laboratories' research interest, followed by a report of the respective fellows' progress. Formal review of the mentor's effectiveness and the fellow's progress and goals are prepared by the Steering Committee, made up of the four Focus Directors. A core curriculum is offered to all fellows, including a "Clinical Research Course", which covers subjects on research design and analysis, ethics, regulatory,issues, grant preparation and responsible conduct of research. Fellows are encouraged to obtain an advanced degree as part of the STAR program, with formal course work in appropriate departments for one or two additional years. Of the 7 fellows who have completed their program during the interval 2002 - present, 2 have obtained the Master's degree and 1 has received a PhD degree. The training of hematologists with expertise in basic, clinical and translational research is an important priority for the David Geffen School of Medicine at UCLA and this application seeks support for the pivotal period between clinical training and an eventual career in academic hematology.

此申请用于在 David Geffen 竞争性更新 PHS 机构国家服务奖 加州大学洛杉矶分校医学院为研究员在血液学领域的学术生涯做好准备。这个奖项是 于 2002 年 7 月启动，并支持血液学/肿瘤内科第二年和第三年的 4 个奖学金名额 训练。已加入该计划的 11 名研究员中，4 人目前正在接受培训，7 人已完成学业 研究员，其中 4 名是加州大学洛杉矶分校的全职教师，两名正在与业界一起进行临床试验开发， 其中一项已进入临床实践。该学院由 31 名学术科学家和医生组成， 分为四个共同研究兴趣领域：造血和干细胞生物学（Kenneth Dorshkind，博士，主任），白血病（Gary Schiller，医学博士，主任），淋巴细胞生物学和淋巴瘤 （Alan Lichtenstein，医学博士，主任）和止血、血栓形成和血管生物学（Victor Marder，医学博士， 导演）。所有教员均获得校外研究资助支持，其中 24 名（77%）获得了 NIH 资助。 与互补学科的其他培训项目的互动强调了我们的互动目标 基础和转化研究职业。研究静修是；每年春天举行，在此期间 导师概述了实验室的研究兴趣，然后是各自实验室的报告 同学们的进步。对导师的有效性以及研究员的进展和目标进行正式审查 由四位焦点董事组成的指导委员会准备。向所有人提供核心课程 研究员，包括“临床研究课程”，涵盖研究设计和分析主题， 道德、监管、问题、拨款准备和负责任的研究行为。鼓励研究员 作为 STAR 计划的一部分，获得高级学位，并参加适当的正式课程 部门再延长一到两年。期间完成项目的 7 名研究员中 2002年至今，2人获硕士学位，1人获博士学位。培训内容 拥有基础、临床和转化研究专业知识的血液学家是重要的优先事项 加州大学洛杉矶分校大卫格芬医学院和该申请寻求对之间的关​​键时期的支持 临床培训和最终的学术血液学职业生涯。